Research Study Evaluating Aplindore in Early Parkinson’s Disease
A clinical study of the research medication Aplindore in persons 30 years of age or older who have early stage Parkinson’s disease is recruiting subjects to participate. The purpose of this research study is to find out whether Aplindore can effectively treat the symptoms of Parkinson’s Disease.
There is no cost to participate in the study. Persons with early stage Parkinson’s disease who are interested in participating in this study should contact the Boston University Parkinson’s Disease and Movement Disorder Center at 617-638-7737.